Deletion of CDKN2A is associated with a poor prognosis in soft tissue sarcomas and is an independent prognostic factor in HPV-negative head and neck squamous cell carcinomas (21, 25). This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.